Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Perrier

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Annales De Chirurgie|January 1, 1997
[Induction treatment of locally advanced operable cancers of the esophagus. Prognostic significance of the histologic response]P Thomas, C Doddoli, A Giacoia, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Recurrence after surgical treatment of epidermoid cancers of the esophagus. Therapeutic approach in 19 patients]J F Seitz, C Renou, H Perrier, et al.
Gastroenterology|August 10, 2000
Covert transmission of hepatitis C virus during bloody fisticuffsM Bourlière, P Halfon, Y Quentin, et al.
Biochemistry|June 15, 1993
Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2I P Street, H K Lin, F Laliberté, et al.
ESMO Open|August 5, 2023
Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimensP du Rusquec, R Guimbaud, K Le Malicot, et al.
British Journal of Cancer|July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancerJ-P Delord, J Bennouna, P Artru, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimizationC Li, N Chauret, L A Trimble, et al.
Journal of Autoimmunity|August 11, 1999
Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteinsN Fabien, A Moreira, J P Lavergne, et al.
British Journal of Cancer|January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'J Bennouna, H Perrier, B Paillot, et al.
Journal of Viral Hepatitis|February 20, 2002
Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug usersM Bourlière, J M Barberin, M Rotily, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Annales De Chirurgie|January 1, 1997
[Induction treatment of locally advanced operable cancers of the esophagus. Prognostic significance of the histologic response]P Thomas, C Doddoli, A Giacoia, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Recurrence after surgical treatment of epidermoid cancers of the esophagus. Therapeutic approach in 19 patients]J F Seitz, C Renou, H Perrier, et al.
Gastroenterology|August 10, 2000
Covert transmission of hepatitis C virus during bloody fisticuffsM Bourlière, P Halfon, Y Quentin, et al.
Biochemistry|June 15, 1993
Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2I P Street, H K Lin, F Laliberté, et al.
ESMO Open|August 5, 2023
Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimensP du Rusquec, R Guimbaud, K Le Malicot, et al.
British Journal of Cancer|July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancerJ-P Delord, J Bennouna, P Artru, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimizationC Li, N Chauret, L A Trimble, et al.
Journal of Autoimmunity|August 11, 1999
Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteinsN Fabien, A Moreira, J P Lavergne, et al.
British Journal of Cancer|January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'J Bennouna, H Perrier, B Paillot, et al.
Journal of Viral Hepatitis|February 20, 2002
Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug usersM Bourlière, J M Barberin, M Rotily, et al.
Pageof 8